Skip to main content

Discontinuation Cluster · SSRI

Zoloft (Sertraline) Onsite Taper

Onsite sertraline (Zoloft) taper bridged with sub-psychoactive iboga total alkaloid under continuous cardiac telemetry.

Generic name

Sertraline

Drug class

SSRI

Half-life class

intermediate

Plasma half-life

≈ 26 hours (active metabolite N-desmethylsertraline ≈ 60–100 hours)

Typical dose range

25–200 mg/day

Onsite taper duration

10–21 days onsite, drug-dependent and dose-dependent

TA bridge

Iboga TA 50–150 mg BID (sub-psychoactive)

DA
Medically reviewed by Dr. Arellano, M.D.
Clinical Director, MindScape Retreat · Board-certified physician specializing in ibogaine-assisted detoxification with over 1,000 patients treated.
Last reviewed: May 2026 · See full medical team

Quick Answer

Can I taper off Zoloft (Sertraline) at MindScape?

Yes. MindScape's onsite taper protocol discontinues Zoloft (Sertraline) under continuous cardiac telemetry by bridging with sub-psychoactive doses (50–150 mg BID (sub-psychoactive)) of full-spectrum iboga total alkaloid (TA) — covering all 12+ indole alkaloids — rather than benzodiazepine cover or unsupervised home washouts. Onsite taper duration is typically 10–21 days onsite, drug-dependent and dose-dependent, driven by the drug's intermediate half-life and the patient's baseline dose. Eligible patients can then proceed to a flood-dose ibogaine HCl reset.

Reviewed by Dr. Arellano, M.D. — May 2026

Withdrawal Profile

  • Brain zaps and electric-shock sensations
  • Vertigo, dizziness, gait instability
  • Insomnia and vivid dreaming
  • Irritability, anxiety surges, derealization
  • Flu-like fatigue and GI distress

Why It's Hard To Taper At Home

  • Patients on sertraline for 6+ months have downregulated serotonin transporter (SERT) density.
  • Hyperbolic dose drops below 25 mg are difficult without compounded liquid or bead-counting.
  • SSRI discontinuation syndrome is frequently misdiagnosed as relapse, leading to unnecessary reinstatement.

MindScape Onsite Protocol

  1. Day 0–2 baseline: 12-lead EKG with QTc, CMP, LFTs, electrolytes, thyroid panel.
  2. Hyperbolic taper: 50% reduction every 5–7 days using compounded liquid until ≤ 5 mg, then full discontinuation.
  3. Iboga TA bridge at 50–150 mg BID covers 5-HT1A/5-HT2A/SERT receptor coverage during the gap.
  4. Continuous cardiac telemetry from pre-medication through 72–96 hours post-flood.
  5. Magnesium pre-loading and electrolyte normalization before any flood-dose ibogaine HCl.

Day-By-Day Patient Experience

  • Days 1–3: clinical workup, baseline assessment, magnesium loading, first half-dose reduction.
  • Days 4–10: hyperbolic dose reductions every 5–7 days; TA bridge covers brain-zaps and dizziness.
  • Days 11–14: full discontinuation under telemetry; symptom-driven supportive care.
  • Days 15–18: ibogaine HCl flood dose if eligibility maintained; integration begins.
  • Days 19–21: 72–96 hour post-flood telemetry tail and discharge planning.

Day-counts and step-cadences are illustrative ranges, not personal medical advice. Individual taper duration is determined onsite by the medical team after baseline workup.

Citations & Reading

  • Horowitz MA, Taylor D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry, 6(6), 538-546.
  • Davies J, Read J. (2019). Addictive Behaviors, 97, 111-121.
  • Glue P, et al. (2016). Clinical Pharmacology in Drug Development, 5(6), 460-468.

For the broader iboga-TA evidence base, see the 2026 evidence-base review and the onsite taper cohort methodology page.

Other SSRI taper guides

Onsite Tapers

Ready to discuss a Zoloft onsite taper?

Our medical team takes clinical calls from prospective patients, family members, and referring clinicians.

Schedule a clinical call

100% Confidential · No Obligation